Trial Profile
Safety and efficacy of blinatumomab in patients with B-Precursor Acute Lymphoblastic Leukemia (ALL)
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 17 Jan 2017
Price :
$35
*
At a glance
- Drugs Blinatumomab (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 17 Jan 2017 New trial record
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.